{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:22:46Z","timestamp":1768594966908,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science Research Cultivation Program of Stomatological Hospital, Southern Medical University","award":["PY2021026"],"award-info":[{"award-number":["PY2021026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-024-04683-y","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:03:01Z","timestamp":1723039381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chronic nonspecific cheilitis associated with tislelizumab treatment in a patient with a history of tongue squamous cell carcinoma: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Haiyue","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"issue":"5","key":"4683_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ajoms.2021.02.001","volume":"33","author":"AKG Gonzaga","year":"2021","unstructured":"Gonzaga AKG, de Bezerra O, Cavalcante HI, Santana IL, de Oliveira T, de Medeiros PT. An update about cheilitis. J Oral Maxillofacial Surg Med Pathol. 2021;33(5):555\u201360.","journal-title":"J Oral Maxillofacial Surg Med Pathol"},{"issue":"2","key":"4683_CR2","first-page":"67","volume":"29","author":"L Lugovic-Mihic","year":"2020","unstructured":"Lugovic-Mihic L, Blagec T, Japundzic I, Skroza N, Delas Adzajic M, Mravak-Stipetic M. Diagnostic management of cheilitis. An approach based on a recent proposal for cheilitis classification. ACTA DERMATOVENEROLOGICA ALPINA PANONICA ET ADRIATICA. 2020;29(2):67\u201372.","journal-title":"ACTA DERMATOVENEROLOGICA ALPINA PANONICA ET ADRIATICA"},{"issue":"2","key":"4683_CR3","first-page":"342","volume":"57","author":"L Lugovi\u0107-Mihi\u0107","year":"2018","unstructured":"Lugovi\u0107-Mihi\u0107 L, Pilipovi\u0107 K, Crnari\u0107 I, \u0160itum M, Duvan\u010di\u0107 T. Differential diagnosis of cheilitis\u2013how to classify cheilitis? Acta Clin Croatica. 2018;57(2):342\u201351.","journal-title":"Acta Clin Croatica"},{"issue":"8","key":"4683_CR4","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1111\/odi.14359","volume":"29","author":"T Blagec","year":"2023","unstructured":"Blagec T, Glavina A, \u0160piljak B, Be\u0161li\u0107 I, Bulat V, Lugovi\u0107-Mihi\u0107 L. Cheilitis: a cross\u2010sectional study\u2014multiple factors involved in the aetiology and clinical features. Oral Dis. 2023;29(8):3360\u201371.","journal-title":"Oral Dis"},{"key":"4683_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12916-016-0623-5","volume":"14","author":"S Farkona","year":"2016","unstructured":"Farkona S, Diamandis EP, Blasutig IM. Cancer immunotherapy: the beginning of the end of cancer? BMC Med. 2016;14:73.","journal-title":"BMC Med"},{"issue":"6","key":"4683_CR6","first-page":"617","volume":"80","author":"A Lee","year":"2020","unstructured":"Lee A, Keam SJ, Tislelizumab. First Approval Drugs. 2020;80(6):617\u201324.","journal-title":"First Approval Drugs"},{"issue":"7","key":"4683_CR7","doi-asserted-by":"publisher","first-page":"8460","DOI":"10.21037\/apm-21-23","volume":"10","author":"L Li","year":"2021","unstructured":"Li L, Lou A, Yu J. Immune checkpoint inhibitor-related pneumonitis induced by camrelizumab: a case report and review of literature. Ann Palliat Med. 2021;10(7):8460\u20136.","journal-title":"Ann Palliat Med"},{"key":"4683_CR8","doi-asserted-by":"publisher","first-page":"1226993","DOI":"10.3389\/fimmu.2023.1226993","volume":"14","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Qin Z, Yan P, Wang Q, Qu J, Chen Y. Immune-related adverse events with severe pain and ureteral expansion as the main manifestations: a case report of tislelizumab-induced ureteritis\/cystitis and review of the literature. Front Immunol. 2023;14:1226993.","journal-title":"Front Immunol"},{"key":"4683_CR9","unstructured":"Guo Q, Jin L, Zhang T, Gao R, Zou K, Fu M et al. Literature analysis of cutaneous adverse reactions induced by tislelizumab. Cutaneous and Ocular Toxicology.1\u20136."},{"key":"4683_CR10","unstructured":"Hon A, Oakley A. DermNet New Zealand."},{"key":"4683_CR11","doi-asserted-by":"publisher","first-page":"104799","DOI":"10.1016\/j.oraloncology.2020.104799","volume":"107","author":"A Almangush","year":"2020","unstructured":"Almangush A, Makitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, et al. Staging and grading of oral squamous cell carcinoma: an update. Oral Oncol. 2020;107:104799.","journal-title":"Oral Oncol"},{"key":"4683_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jconrel.2023.08.055","volume":"362","author":"T Liu","year":"2023","unstructured":"Liu T, Zhou Z, Zhang M, Lang P, Li J, Liu Z, et al. Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor. J Controlled Release. 2023;362:502\u201312.","journal-title":"J Controlled Release"},{"issue":"3","key":"4683_CR13","first-page":"727","volume":"10","author":"Y Han","year":"2020","unstructured":"Han Y, Liu D, Li L. PD-1\/PD-L1 pathway: current researches in cancer. Am J cancer Res. 2020;10(3):727.","journal-title":"Am J cancer Res"},{"key":"4683_CR14","doi-asserted-by":"publisher","first-page":"118297","DOI":"10.1016\/j.lfs.2020.118297","volume":"259","author":"P Lotfinejad","year":"2020","unstructured":"Lotfinejad P, Kazemi T, Mokhtarzadeh A, Shanehbandi D, Niaragh FJ, Safaei S, et al. PD-1\/PD-L1 axis importance and tumor microenvironment immune cells. Life Sci. 2020;259:118297.","journal-title":"Life Sci"},{"key":"4683_CR15","doi-asserted-by":"crossref","unstructured":"Tan CL, Kuchroo JR, Sage PT, Liang D, Francisco LM, Buck J et al. PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance. J Exp Med. 2021;218(1).","DOI":"10.1084\/jem.20182232"},{"issue":"1","key":"4683_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-023-00465-w","volume":"11","author":"D Ye","year":"2023","unstructured":"Ye D, Desai J, Shi J, Liu S-YM, Shen W, Liu T, et al. Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors. Biomark Res. 2023;11(1):1\u201312.","journal-title":"Biomark Res"},{"key":"4683_CR17","doi-asserted-by":"publisher","first-page":"107327482211112","DOI":"10.1177\/10732748221111296","volume":"29","author":"L Zhang","year":"2022","unstructured":"Zhang L, Geng Z, Hao B, Geng Q. Tislelizumab: a modified anti-tumor programmed death receptor 1 antibody. Cancer Control. 2022;29:10732748221111296.","journal-title":"Cancer Control"},{"key":"4683_CR18","doi-asserted-by":"crossref","unstructured":"Gagari E. Cheilitis and oral disease. European handbook of dermatological treatments. Springer; 2023. pp. 137\u201345.","DOI":"10.1007\/978-3-031-15130-9_13"},{"issue":"3","key":"4683_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.14693\/jdi.v25i3.1255","volume":"25","author":"M Mandasari","year":"2018","unstructured":"Mandasari M, Astuti AK, Rahmayanti F. A case of inconspicuous recurrent herpes labialis mimicking unilateral angular cheilitis. J Dentistry Indonesia. 2018;25(3):171\u20134.","journal-title":"J Dentistry Indonesia"},{"issue":"2","key":"4683_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/jop.13142","volume":"50","author":"J Liu","year":"2021","unstructured":"Liu J, Shi L, Wang X, Wu F, Hu M, He J, et al. Tacrolimus 0.03% ointment treatment in exfoliative cheilitis: a randomised controlled clinical trial and monitoring blood concentration. J Oral Pathol Med. 2021;50(2):251\u20139.","journal-title":"J Oral Pathol Med"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-024-04683-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:03:10Z","timestamp":1723039390000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-024-04683-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4683"],"URL":"https:\/\/doi.org\/10.1186\/s12903-024-04683-y","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient provided informed consent for clinical management in this case. Additionally, written consent for publication of their details was obtained from the patient and complied with hospital regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient to publish all clinical data and accompanying images. Additionally, written consent was obtained from the study participant to publish this information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"906"}}